Skip to evidence report

IPSC.mesodermal_primed: Studies — page 10

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,329 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 9,001–10,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for IPSC.mesodermal_primed
#Trait / studyIndividual trait IDMean IC score
9001MANSC4 levelsGCST904698480.02
9002FrecklesGCST0060910.02
9003JAM2/TGFBR2 ratioGCST903152380.02
9004LILRB4 levelsGCST904697780.02
9005aparc-DKTatlas lh thickness precuneusGCST900035630.02
9006CD79B/TNFRSF13B ratioGCST903139020.02
9007HAVCR2 levelsGCST904694320.02
9008Diaphragmatic hernia (PheCode 550.2)GCST904760610.02
9009FLT1/TFPI2 ratioGCST903148560.02
9010IDP dMRI ProbtrackX MO str lGCST900040230.02
9011CALB2 levelsGCST904685270.02
9012CD40LG/EGF ratioGCST903138190.02
9013High-density lipoprotein levels (MTAG)GCST901791470.02
9014T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 3)GCST903208220.02
9015GC levelsGCST901625640.02
9016AMBP/HAVCR1 ratioGCST903132540.02
9017ACY1/GSTA1 ratioGCST903131630.02
9018HippSubfield lh volume Whole-hippocampal-bodyGCST900026870.02
9019GART levelsGCST904693030.02
9020Dronedarone medicationFING000004740.02
9021FCN2 levelsGCST904692040.02
9022Serum 25-Hydroxyvitamin D levels (conditioned on BMI)GCST900006160.02
9023Cholesterol to Total Lipids in Very Large HDL percentageGCST905003240.02
9024Omega-3 fatty acids levelsGCST904991450.02
9025CCL5/TFPI ratioGCST903137080.02
9026ENAH levelsGCST904691060.02
9027Diseases of hair and hair follicles (PheCode 704)GCST904762090.02
9028FCER2/TNFRSF9 ratioGCST903147910.02
9029DPP6/NRCAM ratioGCST903145420.02
9030RELT/TNFRSF1A ratioGCST903157670.02
9031KDR levelsGCST902433230.02
9032COX5B/METAP1D ratioGCST903142010.02
9033White blood cell countGCST900024070.02
9034CEACAM5 levelsGCST904686960.02
9035Phenylacetylcarnitine levelsGCST901999930.02
9036Lysoalkylphosphatidylcholine (O-20:0) levelsGCST900241930.02
9037Mean corpuscular volume | Blood countUKBB000004490.02
9038T1 FreeSurfer aseg 3rd-VentricleGCST903841470.02
9039CC2D1A/STIP1 ratioGCST903136650.02
9040PKLR/UBAC1 ratioGCST903156600.02
9041Triacylglycerol (54:2) [NL-18:0] levelsGCST900251750.02
9042CD46/NID1 ratioGCST903138330.02
9043Illness, injury, bereavement, stress in last 2 years - None of the above | Mental healthUKBB000003390.02
9044Sphinganine-1-phosphate levelsGCST901998450.02
9045CD27/NBL1 ratioGCST903137740.02
9046Speech-in-noise perceptionGCST900447760.02
9047aparc-Desikan lh volume parsopercularisGCST900027850.02
9048Platelet distribution widthGCST0046160.02
9049CRKL/DBNL ratioGCST903142630.02
9050Other diseases of the respiratory systemFING000010110.02
9051Radial styloid tenosynovitis [de Quervain]FING000012370.02
9052Paroxysmal supraventricular tachycardia (PheCode 427.11)GCST904759640.02
9053STX16 levelsGCST904707690.02
9054Total Dihexosylceramide levelsGCST900251930.02
9055IDP dMRI TBSS ICVF Cerebral peduncle RGCST900043410.02
9056Anomalies of dental arch relationship, including avohilmoFING000000910.02
9057LAMA4 levelsGCST904697310.02
9058AZU1 levelsGCST904684080.02
9059GSTA3/KRT18 ratioGCST903149970.02
9060CA4/TGFBR2 ratioGCST903135880.02
9061Myocardial infarction | circulatory systemUKBB000004910.02
9062Phospholipids in HDLGCST904974370.02
9063Total lipids in LDL (UKB data field 23425)GCST902695220.02
9064C9 levelsGCST904685050.02
9065IDP dMRI ProbtrackX ICVF atr rGCST900043780.02
9066CLEC1B/VTA1 ratioGCST903141070.02
9067Cholesteryl Esters in Large LDLGCST904979490.02
9068DKK4/REG1B ratioGCST903144900.02
9069SWAP70 levelsGCST902429310.02
9070FGFBP2 levelsGCST904692310.02
9071Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024150.02
9072EFHD1 levelsGCST904690790.02
9073CFHR5 levelsGCST904687280.02
9074ING1 levelsGCST904696130.02
9075Arthropathy in ulcerative colitisFING000001100.02
9076X-12844 levelsGCST902005230.02
9077red cell diameter width (RDW, maximum, inv-norm transformed)GCST904763550.02
9078Risk taking | Mental healthUKBB000007590.02
9079ST8SIA1 levelsGCST904707540.02
9080Ever unenthusiastic/disinterested for a whole week | Mental healthUKBB000002260.02
9081Operation code - inguinal/femoral hernia repair | OperationsUKBB000005610.02
9082HippSubfield lh volume CA4-bodyGCST900026830.02
9083CCL5/SELP ratioGCST903137050.02
9084IDP dMRI TBSS ICVF Anterior limb of internal capsule RGCST900043430.02
9085EREG levelsGCST904691450.02
9086TNFSF10 levelsGCST902748430.02
9087Total lipids in small LDL (UKB data field 23545)GCST902696420.02
9088IFNGR1 levelsGCST904695130.02
9089CD1C levelsGCST904686040.02
9090aparc-Desikan lh thickness precuneusGCST900034690.02
9091PRCP levelsGCST904703140.02
9092Mackerel likingGCST900947960.02
9093CD209/CLEC4G ratioGCST903137500.02
9094aseg rh intensity PutamenGCST900037840.02
9095PBXIP1 levelsGCST904701640.02
9096Total Cholesteryl ester levelsGCST900251880.02
9097IDP dMRI ProbtrackX ISOVF cgc lGCST900045290.02
9098UPB1 levelsGCST904710130.02
9099Moderate-to-vigorous intensity physical activity during leisure timeGCST901043410.02
9100Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB000008720.02
9101OSM/TGFA ratioGCST903155900.02
9102BDNF levelsGCST904684370.02
9103X-25371 levelsGCST902006560.02
9104IDP dMRI ProbtrackX L1 ptr lGCST900042650.02
9105FCGR3B levelsGCST904692020.02
9106BSG/IL12A_IL12B ratioGCST903135320.02
9107CCN2/TACC3 ratioGCST903137170.02
9108Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB000003020.02
9109Cholesteryl Esters to Total Lipids in Very Large HDL percentageGCST905003590.02
9110TRIM25 levelsGCST904709660.02
9111Nonalcoholic steatohepatitisFING000008790.02
9112Long-standing illness, disability or infirmity | General healthUKBB000004090.02
9113Smoking status - Previous | SmokingUKBB000007810.02
9114Neutrophil percentage of white cells varianceGCST905657010.02
9115APP/EGF ratioGCST903133220.02
9116Late-onset myasthenia gravisGCST904321580.02
9117Herring likingGCST900947810.02
9118Diacylglycerol_44:6_[M+H-H2O]1+ levelsGCST900602450.02
9119CEP170 levelsGCST904687110.02
9120Urine N-acetylglutamate levels in chronic kidney diseaseGCST902655690.02
9121Other specified and unspecified disorders of lensFING000011010.02
9122EpilepsyFING000005110.02
9123Clonal haematopoiesis of indeterminate potential (ASXL1 mutation)GCST901652590.02
9124DOK2/FADD ratioGCST903145300.02
9125Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)FING000011430.02
9126Glycated hemoglobin levelsGCST900022440.02
9127CRELD2 levelsGCST904688590.02
9128GABBR2 levelsGCST902412300.02
9129Recent inability to stop or control worrying | AnxietyUKBB000007420.02
9130HEXIM1/NT5C3A ratioGCST903150480.02
9131FABP1/FABP2 ratioGCST903147500.02
9132Hypotaurine levelsGCST902003790.02
9133Right-hemisphere limbic network to putamen white-matter structural connectivityGCST903028290.02
9134Urinary calculus | genitourinaryUKBB000008860.01
9135Total lipid levels in very large HDLGCST900930100.01
9136Left ventricular end diastole inferolateral wall thicknessGCST902785160.01
9137FOXO1/NFATC1 ratioGCST903148730.01
9138red blood cell count (RBC, mean, inv-norm transformed)GCST904763470.01
9139Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T494ECGA0004940.01
9140monocyte (fraction, mean, inv-norm transformed)GCST904755110.01
9141MSLN levelsGCST904699480.01
9142CXCL5/PLXNA4 ratioGCST903143510.01
9143Cholesterol in small LDL (UKB data field 23547)GCST902696440.01
9144Chronic dermatitis due to solar radiation (PheCode 938.2)GCST904762880.01
9145Dihomo-linoleoylcarnitine (C20:2) levelsGCST902001440.01
9146EREG/TIMP3 ratioGCST903147080.01
9147Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney diseaseGCST902660160.01
9148Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)FING000008650.01
9149Blood cell traits latent factor 5 (platelet)GCST905592470.01
9150Milk type used: Full cream (UKB data field 1418_1)GCST901329380.01
9151GMPR levelsGCST904693680.01
9152Diseases of sebaceous glands (PheCode 706)GCST904762100.01
9153CST3/RARRES2 ratioGCST903142950.01
9154Right-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903028210.01
9155Length of working week for main job | EmploymentUKBB000004050.01
9156high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed)GCST904753480.01
9157T1 CAT volume L VIIIbGCST903841300.01
9158Ceramide (d16:1/22:0) levelsGCST900240260.01
9159FXYD5/TMSB10 ratioGCST903149060.01
9160Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST904352030.01
9161TPPP3 levelsGCST904709480.01
9162InsomniaFING000006830.01
9163DFFA/SIRT2 ratioGCST903144620.01
9164PMVK/PRDX5 ratioGCST903156940.01
9165Cereal type - Other (e.g. Cornflakes, Frosties) | DietUKBB000001250.01
9166mean platelet volume (MPV, maximum, inv-norm transformed)GCST904755170.01
9167Treatment/medication code - seretide 50 evohaler | MedicationsUKBB000008580.01
9168Macular degeneration, dry (PheCode 362.21)GCST904758510.01
9169CPPED1 levelsGCST904688450.01
9170BPIFB1 levelsGCST904684620.01
9171MIF levelsGCST900890180.01
9172T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 8)GCST903208270.01
9173DSCAM levelsGCST904690410.01
9174CD84/SDC4 ratioGCST903139160.01
9175FAM3B/GUCA2A ratioGCST903147790.01
9176IDP T1 FAST ROIs brain stemGCST900025610.01
9177Phosphatidylcholine (40:8) levelsGCST900242990.01
9178PTPRK levelsGCST904703830.01
9179LYN/YES1 ratioGCST903153510.01
9180Collagenous colitisGCST902041450.01
9181Glucose levelsGCST901327240.01
9182AHCY/HSPA1A ratioGCST903132110.01
9183ANGPT1/SERPINE1 ratioGCST903132690.01
9184CC2D1A/STAMBP ratioGCST903136640.01
9185Other localized connective tissue disordersFING000010660.01
9186Monocyte countGCST900023930.01
9187Biological Mother: Cancer, BreastGCST904754850.01
9188WorryGCST0064780.01
9189T1 FreeSurfer a2009s lh S temporal sup areaGCST903847400.01
9190F2R/SEMA4D ratioGCST903147340.01
9191CXCL8 levelsGCST904689340.01
9192Skin colour | Sun exposureUKBB000007730.01
9193X-12038 levelsGCST902436830.01
9194rfMRI connectivity (ICA100 edge 387)GCST900052400.01
9195RTN4IP1 levelsGCST904705070.01
9196Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levelsGCST902001050.01
9197Two-hour glucoseGCST900022270.01
9198Dissociative [conversion] disordersFING000004680.01
9199Macular cystFING000007430.01
9200KIF22 levelsGCST904696820.01
9201CST3/DEFA1_DEFA1B ratioGCST903142910.01
9202Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levelsGCST900257430.01
9203Serum creatinine levelsGCST900187590.01
9204CD163/MARCO ratioGCST903137370.01
9205FGFR2/TGFBR2 ratioGCST903148130.01
9206Cleft hard palate NOSFING000003060.01
9207Blood cell traits latent factor 18 (platelet)GCST905592600.01
9208SERPINE1/VASH1 ratioGCST903158360.01
9209IGF1R levelsGCST904695240.01
9210CA4/FOLR2 ratioGCST903135850.01
9211monocyte (fraction, maximum, inv-norm transformed)GCST904755080.01
9212Worrier / anxious feelings | Mental healthUKBB000009210.01
9213CFHR2 levelsGCST904687260.01
9214Right-hemisphere control network to hippocampus white-matter structural connectivityGCST903028400.01
9215Frailty (Factor 6 - Disability)GCST906240520.01
9216RAPGEF2 levelsGCST904704260.01
9217PINLYP levelsGCST904702380.01
9218Nonsuppurative otitis mediaFING000008850.01
9219T1 FreeSurfer a2009s rh S temporal sup areaGCST903849620.01
9220CD69/TIA1 ratioGCST903138880.01
9221ARHGAP25 levelsGCST904683530.01
9222Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900254340.01
9223X-12510--2-aminooctanoic acid levelsGCST902437480.01
92241-methylhistidine levelsGCST901996910.01
9225Lysoalkenylphosphatidylethanolamine (P-20:0) levelsGCST900254600.01
9226Non-cancer illness code, self-reported - depression | Medical conditionsUKBB000005070.01
9227Carboplatin drug response (IC50)GCST900117830.01
9228Sphingomyelins levels (UKB data field 23438)GCST902695350.01
9229Fed-up feelings | Mental healthUKBB000002420.01
9230Breast cancerGCST0049880.01
9231Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489ECGA0004890.01
9232KeloidGCST900186540.01
9233AXIN1/DOK2 ratioGCST903134060.01
9234Right-hemisphere limbic network to caudate white-matter structural connectivityGCST903028280.01
9235Gestational [pregnancy-induced] hypertensionFING000005710.01
9236rfMRI connectivity (ICA100 edge 1011)GCST900058640.01
9237Salty food likingGCST900948280.01
9238MZB1 levelsGCST904699870.01
9239Mean corpuscular volume (UKB data field 30040)GCST904680860.01
9240PAXX levelsGCST904701610.01
9241CKAP2 levelsGCST902408660.01
9242PsoriasisGCST904681470.01
9243CFHR4 levelsGCST904687270.01
9244TNFRSF19 levelsGCST904709090.01
9245CLEC7A levelsGCST904687780.01
9246Current employment status - Retired | EmploymentUKBB000001590.01
9247CAMK1D levelsGCST902405560.01
9248Lymphoid leukaemia (controls excluding all cancers)FING000007410.01
9249TNFRSF6B levelsGCST904709140.01
9250Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441ECGU0004410.01
9251CD83/TREM2 ratioGCST903139080.01
9252Phospholipids to total lipids in medium LDL percentage (UKB data field 23619)GCST902697160.01
9253Maternal care for other conditions predominantly related to pregnancyFING000007910.01
9254Monocyte percentage of white cellsGCST900023940.01
9255ATF6 levelsGCST906172600.01
9256Recent feelings of foreboding | AnxietyUKBB000007380.01
9257Left-hemisphere dorsal attention network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026970.01
9258LAMP3/PRSS8 ratioGCST903152750.01
9259METAP1D/PLXNA4 ratioGCST903154270.01
9260Colitis, primary sclerosing, strict definitionFING000003130.01
9261Cerebrospinal fluid 5-methylthioadenosine (MTA) levelsGCST903182160.01
9262Myocardial fractal dimension (slice 6)GCST900002920.01
9263T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST903208210.01
9264Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T493ECGA0004930.01
9265Basophil countGCST900022920.01
9266CR2 levelsGCST904688520.01
9267PLXNA4/VASH1 ratioGCST903156910.01
9268VegetarianismGCST904288380.01
9269KLK6 levelsGCST900120080.01
9270GNS levelsGCST900884600.01
9271Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T498ECGA0004980.01
9272CIAPIN1/SNX9 ratioGCST903140680.01
9273TSPAN1 levelsGCST904709780.01
9274Raw carrot likingGCST900948180.01
9275Activities undertaken to treat anxiety | AnxietyUKBB000000090.01
9276Plum likingGCST900948120.01
9277Atrophic disorders of skinFING000001290.01
9278NFE2 levelsGCST904700350.01
9279Undecenoylcarnitine (C11:1) levelsGCST902002360.01
9280SPINT2/TNFSF13 ratioGCST903158790.01
9281Triglycerides in large HDLGCST904978820.01
9282DTI TBSS L3 Superior fronto-occipital fasciculus RGCST903845660.01
9283CABP2 levelsGCST904685190.01
9284HGF/TNFSF14 ratioGCST903150600.01
9285AMBP/RARRES2 ratioGCST903132560.01
9286Deforming dorsopathiesFING000003850.01
9287CEP43/TIA1 ratioGCST903140210.01
9288CGA levelsGCST904687320.01
9289Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemiaGCST906247440.01
9290Conductive hearing loss (PheCode 389.2)GCST904759120.01
9291CD40 levelsGCST900120650.01
9292Right-hemisphere control network to amygdala white-matter structural connectivityGCST903028410.01
9293PAG1 levelsGCST904701470.01
9294EGLN1/LSP1 ratioGCST903146170.01
9295T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855340.01
9296T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903206410.01
9297AGXT/GRPEL1 ratioGCST903132050.01
9298Ulcer of lower limb, not elsewhere classifiedFING000013850.01
9299ATOX1/SNAP29 ratioGCST903133740.01
9300CD19 on IgD- CD27- B cellGCST900017320.01
9301CCL7 levelsGCST904685850.01
9302FUT8/TNFSF14 ratioGCST903148950.01
9303EGLN1/PIK3AP1 ratioGCST903146190.01
9304Left-hemisphere default mode network to hippocampus white-matter structural connectivityGCST903027710.01
9305EIF2AK2 levelsGCST904690910.01
9306DTI TBSS L3 Cingulum hippocampus LGCST903845610.01
93075-oxoproline levelsGCST902434370.01
9308CTSS levelsGCST904689160.01
9309MNDA/NCF2 ratioGCST903154720.01
9310KLRB1 levelsGCST904697090.01
9311FSTL3/SPON2 ratioGCST903148840.01
9312Triacylglycerol_50:4_[M+NH4]1+ levelsGCST900604660.01
9313Takes medication for Thyroid problems?GCST904752770.01
9314Feeling miserableGCST0069430.01
9315Phospholipids in medium LDL (UKB data field 23539)GCST902696360.01
9316NIT1 levelsGCST904700500.01
9317Ulcerative rectosigmoiditisFING000013940.01
9318Illnesses of siblings - High blood pressure | Family historyUKBB000003520.01
9319HippSubfield lh volume molecular-layer-HP-headGCST900026770.01
9320Pancreas iron contentGCST900166760.01
9321DTI TBSS L1 Cingulum cingulate gyrus LGCST903844630.01
9322Placental weight (maternal genotype, adjusted for sex and gestational age)GCST902751900.01
9323Graves disease, strict definitionFING000005920.01
9324RLN2 levelsGCST904704740.01
9325Ceramide (d17:1/22:0) levelsGCST900240320.01
9326UrolithiasisGCST900187150.01
9327DSG3/SPINK5 ratioGCST903145610.01
9328T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86)GCST903206490.01
9329Calculus of kidney | genitourinaryUKBB000001150.01
9330Rhodanobacter abundance in stoolGCST900325360.01
9331Generalized anxiety disorderFING000005660.01
9332Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T497ECGA0004970.01
9333GP2 levelsGCST904693820.01
9334Placental weight (maternal genotype, adjusted for sex)GCST902751980.01
9335ObesityFING000008950.01
9336Other disorders of eyelids (PheCode 374)GCST904758900.01
9337CCL22 levelsGCST904685740.01
9338Bilirubin (E,Z or Z,E) levelsGCST902437500.01
9339Valine levels (UKB data field 23467)GCST902695640.01
9340Treatment/medication code - perindopril | MedicationsUKBB000008540.01
9341ICD10 C53: Malignant neoplasm of cervix uteriGCST904542020.01
9342Cholesteryl ester levels in large HDLGCST900928460.01
9343Pregnenetriol sulfate levelsGCST902002410.01
9344TNFSF12/TNFSF13 ratioGCST903159410.01
9345Statin-associated type 2 diabetes mellitusGCST906525170.01
9346EBAG9/FKBP5 ratioGCST903145640.01
9347AKR7L levelsGCST904682750.01
9348Contracture of palmar fascia [Dupuytren's disease] (PheCode 728.71)GCST904762450.01
9349MSRA/SNAP29 ratioGCST903155000.01
9350CSF1/IFNGR1 ratioGCST903142830.01
9351Subarachnoid hemorrhageGCST900187030.01
9352MB levelsGCST900120470.01
9353PARP1/TCL1A ratioGCST903156020.01
9354rfMRI amplitudes (ICA100 node 15)GCST900046030.01
9355TMSB10/TRIAP1 ratioGCST903159249.99e-03
9356CD99L2/RARRES2 ratioGCST903139279.99e-03
9357Ceramide (d16:1/24:0) levelsGCST900252669.98e-03
9358Coagulation defects (PheCode 286)GCST904757969.97e-03
9359ENO2/PLXNA4 ratioGCST903146659.97e-03
9360INPP5J levelsGCST904696189.91e-03
9361PSTPIP2 levelsGCST904703669.91e-03
9362triglyceride (maximum, inv-norm transformed)GCST904764299.89e-03
9363ST6GALNAC2 levelsGCST902402519.87e-03
9364IDP T1 SIENAX CSF normalised volumeGCST900024289.84e-03
9365AAGAB levelsGCST906174739.83e-03
9366Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T445ECGU0004459.81e-03
9367PCDH17/SEMA7A ratioGCST903156059.80e-03
9368Diabetes mellitus | endocrine/metabolicUKBB000001699.80e-03
9369Total Alkenylphosphatidylcholine levelsGCST900258359.77e-03
9370Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439ECGU0004399.75e-03
9371EFNA4/VWC2 ratioGCST903146079.74e-03
9372T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87)GCST903209069.74e-03
9373NBN levelsGCST904700029.72e-03
9374RILP/RWDD1 ratioGCST903157789.72e-03
9375DNMBP/TBC1D5 ratioGCST903145199.72e-03
9376PPL levelsGCST904702949.69e-03
9377NDUFB7 levelsGCST904700159.69e-03
9378Omega-3 fatty acids to total fatty acids percentageGCST905024489.67e-03
9379Cereal type: Other (e.g. Cornflakes, Frosties) (UKB data field 1468_5)GCST901329739.63e-03
9380IL1R1 levelsGCST904255639.58e-03
9381Triacylglycerol (54:1) [NL-18:1] levelsGCST900245639.58e-03
9382SLC27A4/TDRKH ratioGCST903158519.49e-03
9383Total lipids in very large HDLGCST905004109.48e-03
9384TRIM24 levelsGCST904709659.48e-03
9385T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36)GCST903208559.46e-03
9386IL4R levelsGCST904695989.38e-03
9387SELP/VSIR ratioGCST903158229.35e-03
9388Concentration of small HDL particlesGCST904994649.35e-03
9389BPIFB1/GLRX ratioGCST903135309.34e-03
9390CCN2/VEGFC ratioGCST903137199.34e-03
9391IDP T1 SIENAX CSF unnormalised volumeGCST900024299.33e-03
9392GZMB/IL15 ratioGCST903150159.32e-03
9393Hair colour (natural, before greying): Blonde (UKB data field 1747_1)GCST900418369.29e-03
9394aparc-DKTatlas lh volume parsopercularisGCST900028789.27e-03
9395MZT1 levelsGCST904699889.27e-03
9396mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754489.26e-03
9397Irritability | Mental healthUKBB000003809.26e-03
9398CC2D1A levelsGCST904685579.26e-03
9399Citrate levelsGCST904972069.22e-03
9400Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levelsGCST900257359.20e-03
9401TACC3/TRIAP1 ratioGCST903159019.17e-03
9402CD164/NUDT5 ratioGCST903137429.14e-03
9403CDC37/SNAP29 ratioGCST903139359.14e-03
9404Phospholipids to total lipids ratio in small HDLGCST900929539.12e-03
9405HMOX2/TDRKH ratioGCST903150679.12e-03
9406TACSTD2 levelsGCST904707989.04e-03
9407Docosahexaenoic acid to total fatty acids percentageGCST905022689.04e-03
9408Atrial fibrillation/atrial flutterGCST900185769.03e-03
9409CDSN/KLK8 ratioGCST903139969.03e-03
9410IL34 levelsGCST904695939.02e-03
9411CD274 levelsGCST902748328.99e-03
9412CDH5/PEAR1 ratioGCST903139598.98e-03
9413Alcohol drinker status - Never | AlcoholUKBB000000228.98e-03
9414CD209/CLEC14A ratioGCST903137498.98e-03
9415Phosphate levelsGCST902003938.95e-03
9416Bread intake (UKB data field 1438)GCST904681628.94e-03
9417Chronic myeloproliferative diseaseFING000002948.92e-03
9418Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB000003698.85e-03
9419Dissection of aortaFING000004678.83e-03
9420Total lipids in small HDLGCST904994568.83e-03
9421chloride (mean, inv-norm transformed)GCST904751948.81e-03
9422MANSC1/PODXL2 ratioGCST903153718.80e-03
9423Use of sun/uv protection | Sun exposureUKBB000008878.80e-03
9424PLXNA4/SKAP2 ratioGCST903156858.80e-03
9425Concentration of very large HDL particlesGCST905004368.79e-03
9426SMTN levelsGCST904706898.79e-03
9427Medication use (glucocorticoids)GCST900187808.79e-03
9428Hair colour (natural, before greying) - Blonde | Sun exposureUKBB000002968.78e-03
9429Phospholipids to Total Lipids in Large HDL percentageGCST904978638.78e-03
9430VSTM1 levelsGCST904710558.78e-03
9431IL6ST/PDGFRA ratioGCST903151698.78e-03
9432CD36 levelsGCST904686278.76e-03
9433T1 FreeSurfer aseg Right-PallidumGCST903841648.74e-03
9434FADD/PTPN6 ratioGCST903147758.69e-03
9435mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST904754468.68e-03
9436AIFM1/EGF ratioGCST903132198.67e-03
9437TNFSF11 levelsGCST902748448.64e-03
9438DECR1/MAP2K6 ratioGCST903144478.59e-03
9439CASP8 levelsGCST904685488.56e-03
9440Fruit intake (weighted GWA)GCST902672838.51e-03
9441Omega-3 fatty acids to total fatty acids percentageGCST905020888.43e-03
9442Oily fish intake | DietUKBB000005478.43e-03
9443Operation code - cholecystectomy/gall bladder removal | OperationsUKBB000005548.42e-03
9444Bread consumption (slices per week) (UKB data field 1438)GCST901329818.41e-03
9445L1CAM levelsGCST904697238.37e-03
9446Benign mammary dysplasiaFING000001518.37e-03
9447CRKL/PLA2G4A ratioGCST903142718.36e-03
9448Asthma-related acute respiratory infectionsFING000001178.35e-03
9449Degree of unsaturationGCST905022248.33e-03
9450SEL1L levelsGCST904705648.31e-03
9451Other embolism and thrombosisFING000010438.31e-03
9452CD40/IGSF8 ratioGCST903138158.30e-03
9453Other retinal disordersFING000010948.28e-03
9454Cholesteryl Esters to Total Lipids in Large HDL percentageGCST904977638.27e-03
9455Wet age-related macular degenerationFING000014488.27e-03
9456Myocardial fractal dimension (slice 4)GCST900002908.23e-03
9457AFM levelsGCST904682498.22e-03
9458LSIL lesion of the cervix uteriFING000007328.22e-03
9459Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T432ECGU0004328.22e-03
9460Carotid plaqueGCST0074358.19e-03
9461Cholesterol to Total Lipids in Large HDL percentageGCST904977308.15e-03
9462DECR1/STX8 ratioGCST903144528.15e-03
9463RBP5 levelsGCST904704398.13e-03
9464Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T442ECGU0004428.12e-03
9465T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 30)GCST903208498.12e-03
9466Feeling worryGCST0069508.10e-03
9467MAX/STK24 ratioGCST903154048.09e-03
9468Malignant neoplasm of kidney, except pelvis (PheCode 189.11)GCST904755978.08e-03
9469Hammer toe (acquired) (PheCode 735.21)GCST904762508.08e-03
9470CKAP4 levelsGCST904687588.05e-03
9471RFC4 levelsGCST904704608.04e-03
9472FABP1/LGALS4 ratioGCST903147528.03e-03
9473Salami likingGCST900948258.03e-03
9474Other menopausal disordersFING000010717.98e-03
9475N2-acetyl,N6,N6-dimethyllysine levelsGCST902006977.98e-03
9476SCLY/SORD ratioGCST903158167.95e-03
9477DGKA levelsGCST904689897.93e-03
9478IBD (strict) with PSCFING000006577.93e-03
9479Nasal polyps (PheCode 471)GCST904760197.93e-03
9480aparc-Desikan rh area caudalmiddlefrontalGCST900031107.89e-03
9481PEAR1/SCARF1 ratioGCST903156427.87e-03
9482DOK2/SNX9 ratioGCST903145397.83e-03
9483CD79B/FCRL1 ratioGCST903138997.83e-03
9484Prostate cancerGCST0060857.82e-03
9485ELOA/MAD1L1 ratioGCST903146407.82e-03
9486Zoster infectionGCST900187217.81e-03
9487KIRREL2 levelsGCST904696907.81e-03
9488HippSubfield lh volume GC-ML-DG-bodyGCST900026817.78e-03
9489Right-hemisphere limbic network to thalamus white-matter structural connectivityGCST903028277.77e-03
9490Turnip likingGCST900948617.76e-03
9491IL19 levelsGCST904695687.75e-03
9492CLK2 levelsGCST902409757.73e-03
94934-androsten-3beta,17beta-diol disulfate 1 levelsGCST902438797.72e-03
9494Nasal polyps | respiratoryUKBB000004947.71e-03
9495Phenylacetylglutamate levelsGCST902000697.70e-03
9496PTPRF/SDC1 ratioGCST903157527.68e-03
9497KCTD5 levelsGCST904696707.68e-03
9498End-diastolic bi-ventricular shape (principal component 9)GCST904484887.65e-03
94991-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite levelGCST906164057.65e-03
9500red blood cell count (RBC, mean, inv-norm transformed)GCST904763497.61e-03
9501TYMP levelsGCST904709967.60e-03
9502CANT1/NUDT5 ratioGCST903136197.59e-03
9503Length of time at current address | HouseholdUKBB000004047.59e-03
9504VEGFD levelsGCST900120697.58e-03
9505CXCL11/DKK1 ratioGCST903143347.57e-03
9506Physical activity (Total log acceleration 8am-10am)GCST900614137.54e-03
9507CDH5/ENG ratioGCST903139547.53e-03
9508Benign neoplasm of colon, rectum, anus and anal canalFING000001557.52e-03
9509Omega-3 fatty acids to total fatty acids percentageGCST905020827.52e-03
9510Myocardial fractal dimension (slice 8)GCST900002947.51e-03
9511Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440ECGU0004407.50e-03
9512Glaucoma | GlaucomaUKBB000002867.47e-03
9513HSIL lesion of the cervix uteri, vagina or vulvaFING000006257.46e-03
9514Cholesterol levels in large HDLGCST900928447.45e-03
9515DTI autoptx MD atr l tractGCST903852227.39e-03
9516DEFA1_DEFA1B/LCN2 ratioGCST903144547.38e-03
9517X-18922 levelsGCST902005787.37e-03
9518FABP3 levelsGCST904691757.36e-03
9519Propionylcarnitine levelsGCST902435937.35e-03
9520ICAM1/SELE ratioGCST903151167.34e-03
9521Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T236ECGU0002367.33e-03
9522Glomerular diseasesFING000005817.33e-03
9523Non-seminoma of testis, excluding all cancers (controls excluding all cancers)FING000008747.31e-03
9524Internal derangement of knee (PheCode 835)GCST904762827.27e-03
9525Birth asphyxiaFING000002187.26e-03
9526PTH levelsGCST904703727.25e-03
9527Linoleic acid levelsGCST905020097.25e-03
9528SEMA3F levelsGCST904705707.24e-03
9529CCL20 levelsGCST900120777.24e-03
9530FCER2/TREML2 ratioGCST903147927.24e-03
9531Hypertrophic scarFING000006427.22e-03
9532NXF1 levelsGCST902421497.20e-03
9533Prescriptions - paracetamol | antipyreticUKBB000006967.19e-03
9534Prescriptions - antipyreticUKBB000006657.19e-03
9535ThalamNuclei lh volume VPLGCST900027177.19e-03
9536CTSO levelsGCST901792777.17e-03
9537Phospholipids to total lipids in IDL percentage (UKB data field 23609)GCST902697067.17e-03
9538SPARCL1 levelsGCST902428707.17e-03
9539CXCL16 levelsGCST904689287.15e-03
9540Tobacco useFING000013657.13e-03
9541MUC13 levelsGCST904699637.06e-03
9542Operative procedures - Angiocardiography of left side of heart NEC | Summary OperationsUKBB000005727.05e-03
9543UBA9475 sp002161235 abundance in stoolGCST900326357.04e-03
9544Mineral and other dietary supplements - Calcium | MedicationUKBB000004717.04e-03
9545EpiscleritisFING000005137.03e-03
9546Endometriosis of pelvic peritoneumFING000005027.02e-03
9547Phospholipid levels in medium LDLGCST900929126.95e-03
9548Gout, unspecifiedFING000005896.95e-03
9549PRCP/SELE ratioGCST903157266.94e-03
9550SCARF1/SUSD1 ratioGCST903158116.92e-03
9551Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST900418376.91e-03
9552DRAXIN levelsGCST904690386.91e-03
9553Prurigo nodularisFING000012206.88e-03
9554ADA2 levelsGCST904682156.85e-03
9555YOD1 levelsGCST904710906.85e-03
9556LY96/ST6GAL1 ratioGCST903153486.85e-03
9557CNST/ITGB1BP2 ratioGCST903141586.83e-03
9558ATXN10/PRTFDC1 ratioGCST903133986.81e-03
9559CD14 levelsGCST904685986.80e-03
9560Late-onset myasthenia gravisGCST900934666.77e-03
9561Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T496ECGA0004966.77e-03
9562SpondyloarthritisFING000013236.76e-03
9563CD46/SIAE ratioGCST903138356.73e-03
9564Suffer from 'nerves' | Mental healthUKBB000007996.71e-03
9565Dihexosylceramide (d18:1/22:0) levelsGCST900253486.71e-03
9566FAM3B levelsGCST904691866.67e-03
9567LAYN levelsGCST904697426.65e-03
9568RGMB levelsGCST904704646.64e-03
9569Degree of unsaturationGCST905027486.60e-03
9570CholecystitisFING000002746.60e-03
9571HippSubfield rh volume molecular-layer-HP-headGCST900026996.58e-03
9572MVK/SERPINE1 ratioGCST903155056.57e-03
9573Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST906684856.54e-03
9574MMP8/TGFA ratioGCST903154666.53e-03
9575Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T492ECGA0004926.53e-03
9576LTBR/TNFRSF14 ratioGCST903153406.53e-03
9577PTS levelsGCST904703906.50e-03
9578Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T495ECGA0004956.50e-03
9579CD59/CST6 ratioGCST903138576.49e-03
9580IL15 levelsGCST904695566.48e-03
9581PPT1 levelsGCST904277186.47e-03
9582Irregular mensesFING000007016.47e-03
9583Other disorders of skin and subcutaneous tissueFING000010356.46e-03
9584Melanomas of skin (PheCode 172.11)GCST904755786.46e-03
9585Docosahexaenoic acid levelsGCST905019866.46e-03
9586STX6 levelsGCST904707746.45e-03
9587Muscular dystrophyFING000008486.42e-03
9588White blood cell countGCST900023746.42e-03
9589Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB000003716.40e-03
9590Cardiorespiratory fitness (vo2 max)GCST900933176.38e-03
9591REN levelsGCST900120386.37e-03
9592Membranous nephropathyGCST0100066.36e-03
9593DAPP1/PMVK ratioGCST903143966.36e-03
9594TLR4 levelsGCST904708806.35e-03
9595ALDH1A1/SORD ratioGCST903132486.35e-03
9596Renal failureFING000012506.34e-03
9597ANP32B levelsGCST902401766.34e-03
9598CRADD/STAMBP ratioGCST903142446.33e-03
9599NOTCH2 levelsGCST904700666.31e-03
9600T1 FIRST volume L PutaGCST903839876.31e-03
9601HTRA2/SNAP29 ratioGCST903150986.30e-03
9602Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T438ECGU0004386.29e-03
9603HEPACAM2 levelsGCST904694456.29e-03
9604CCL11 levelsGCST904685646.29e-03
96051,5-anhydroglucitol (1,5-ag) levelsGCST902435296.29e-03
9606Phospholipids to Total Lipids in Very Large HDL percentageGCST905004746.27e-03
9607ADD1 levelsGCST904682336.26e-03
9608EBAG9/HBEGF ratioGCST903145656.26e-03
9609COMP/TGFBI ratioGCST903141926.23e-03
9610PGR levelsGCST904702236.22e-03
9611Insulin fold change during an oral glucose tolerance testGCST902675686.21e-03
9612mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST904754446.21e-03
9613Trigger fingerGCST901049076.18e-03
9614X-21286 levelsGCST902005626.17e-03
9615Rubneribacter sp002159915 abundance in stoolGCST900325416.15e-03
9616aparc-DKTatlas lh area superiorparietalGCST900032616.14e-03
9617Right-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903027996.14e-03
9618Phosphatidylcholine (40:8) levelsGCST900255386.13e-03
9619PLAUR levelsGCST900120516.13e-03
9620PFKFB2/SRP14 ratioGCST903156506.12e-03
9621FADD/NCK2 ratioGCST903147706.11e-03
9622CEBPB/PXN ratioGCST903140086.10e-03
9623Asthma-related infectionsFING000001186.05e-03
9624NRP2 levelsGCST904700866.03e-03
9625Citrate levelsGCST900928136.03e-03
9626aparc-Desikan lh area superiorparietalGCST900031016.02e-03
9627GABARAPL1 levelsGCST904692876.01e-03
9628GALNT3 levelsGCST904692976.01e-03
9629Recent worrying too much about different things | AnxietyUKBB000007466.01e-03
9630CCN3/PGF ratioGCST903137226.00e-03
9631Major depressive disorder (probable)GCST0059046.00e-03
9632Plasma X-26054 levels in chronic kidney diseaseGCST902668585.98e-03
9633Childhood sunburn occasions | Sun exposureUKBB000001305.97e-03
9634PDCD5 levelsGCST904701825.97e-03
9635AHCY/FABP5 ratioGCST903132085.97e-03
9636CA2/UBAC1 ratioGCST903135835.95e-03
9637Docosahexaenoic acid to total fatty acids percentageGCST905022845.94e-03
9638ATXN10 levelsGCST904684015.94e-03
9639Volume of right lateral nucleusGCST904750395.93e-03
9640ASS1 levelsGCST904683805.93e-03
9641Urine glucosaminate levels in chronic kidney diseaseGCST902651795.91e-03
9642Free Cholesterol to Total Lipids in Large HDL percentageGCST904977935.89e-03
9643IL6ST/TYRO3 ratioGCST903151705.88e-03
9644PPP1R12A/SPARC ratioGCST903157125.86e-03
9645GP2/LGALS8 ratioGCST903149615.86e-03
9646IRAG2 levelsGCST904696265.85e-03
9647DPP4 levelsGCST904690335.84e-03
9648CLEC4G/LGALS4 ratioGCST903141205.84e-03
9649Leucine levelsGCST902434055.83e-03
9650PAMR1/RARRES2 ratioGCST903155955.83e-03
9651KDM3A levelsGCST904696715.82e-03
9652B4GALT1/B4GAT1 ratioGCST903134295.80e-03
9653CST6/FABP9 ratioGCST903143015.79e-03
9654NMT1 levelsGCST904700595.79e-03
9655CR2/TNFRSF13B ratioGCST903142255.79e-03
9656PPBP levelsGCST904702895.75e-03
9657LGALS4/TIE1 ratioGCST903153165.75e-03
9658F-sweet food liking (derived food-liking factor)GCST900948545.73e-03
9659Operation code - spinal laminectomy | OperationsUKBB000005645.72e-03
9660Right-hemisphere default mode network to amygdala white-matter structural connectivityGCST903028495.71e-03
9661Liver enzyme levels (alkaline phosphatase)GCST900134065.70e-03
9662rfMRI connectivity ICA-features 4GCST900063425.68e-03
9663Creatinine levels (UKB data field 23478)GCST902695755.64e-03
9664CANT1 levelsGCST904685365.64e-03
9665Isolated hypothyroxinemia in pregnancyGCST904351985.64e-03
9666Bacterial pneumoniaeFING000001395.63e-03
9667Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T435ECGU0004355.62e-03
9668Ever smoked | SmokingUKBB000002215.60e-03
9669AP1G2 levelsGCST904683235.59e-03
9670Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST900931135.59e-03
9671CELSR2 levelsGCST904687035.58e-03
9672RETN/RNASET2 ratioGCST903157685.58e-03
9673Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T437ECGU0004375.58e-03
9674PLAUR levelsGCST904702515.54e-03
9675Crohns diseaseGCST904681215.54e-03
9676CRHBP/TREM2 ratioGCST903142605.51e-03
9677Duration of heavy DIY | Physical activityUKBB000001955.51e-03
9678CD164/SIAE ratioGCST903137445.50e-03
9679Right-hemisphere salience/ventral attention network to putamen white-matter structural connectivityGCST903028195.49e-03
968021-hydroxypregnenolone disulfate levelsGCST901998495.49e-03
9681Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T477ECGA0004775.48e-03
9682Lysophosphatidylcholine (26:0) [sn2] levelsGCST900254285.45e-03
9683CDSN/NECTIN4 ratioGCST903139985.44e-03
9684TRIM5 levelsGCST904709705.44e-03
9685Ceramide (d16:1/24:0) levelsGCST900240275.42e-03
9686RNASE4 levelsGCST904704785.41e-03
9687GSTA1/RBP5 ratioGCST903149955.41e-03
9688PPP1R2/TMSB10 ratioGCST903157215.40e-03
9689Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T476ECGA0004765.40e-03
9690Acquired toe deformities (PheCode 735.2)GCST904762495.39e-03
9691PTPRF/PTPRS ratioGCST903157515.38e-03
9692wg lh intensity-contrast pericalcarineGCST900038125.38e-03
9693CLMP/TNFRSF19 ratioGCST903141365.37e-03
9694EIF4G1/TBC1D23 ratioGCST903146395.37e-03
9695ADH4 levelsGCST904682445.36e-03
9696acne vulgarisGCST902458185.34e-03
9697RBM17 levelsGCST904704345.34e-03
9698SLMAP levelsGCST904706735.33e-03
9699red cell diameter width (RDW, minimum, inv-norm transformed)GCST904763635.29e-03
9700Frequency of depressed mood in last 2 weeks | Mental healthUKBB000002595.29e-03
9701CLU levelsGCST904687935.28e-03
9702LAP3 levelsGCST904697375.27e-03
9703Eye problems/disorders - Glaucoma | EyesightUKBB000002315.26e-03
9704Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631)GCST902697285.26e-03
9705Glomerular filtration rate in non diabetics (creatinine)GCST0034015.26e-03
9706Urea levels (UKB data field 30670)GCST904681085.25e-03
9707TXN levelsGCST904709955.25e-03
9708Oral glucose tolerance test-2hGCST902977905.21e-03
9709Total lipids in large HDLGCST904978155.20e-03
9710SLC39A14 levelsGCST904706605.20e-03
9711Sleep apnoea, including avohilmoFING000013105.17e-03
9712CCN2/EDAR ratioGCST903137115.17e-03
9713COMMD1 levelsGCST904688255.16e-03
9714JCHAIN levelsGCST904696615.13e-03
9715SNAP25 levelsGCST904220835.12e-03
9716GET3 levelsGCST904693245.10e-03
9717ATOX1/TMSB10 ratioGCST903133775.09e-03
9718Campesterol levelsGCST901997255.09e-03
97192-aminobutyrate levelsGCST902435845.08e-03
9720CA5A/GSTA1 ratioGCST903135915.08e-03
9721TOR1AIP1 levelsGCST904709355.07e-03
9722Glaucoma | sense organsUKBB000002875.04e-03
9723PDGFB/UXS1 ratioGCST903156345.01e-03
9724POMC levelsGCST904702845.00e-03
9725PDGFRA levelsGCST904210935.00e-03
9726DSG4/FABP9 ratioGCST903145624.99e-03
9727Total Phosphatidylcholine levelsGCST900252044.97e-03
9728KLK8 levelsGCST904697074.96e-03
9729MAP2K6/NT5C3A ratioGCST903153744.96e-03
9730Type 1 diabetes, definitions combinedFING000013804.95e-03
9731EPPK1 levelsGCST904691374.95e-03
9732ALDH1A1 levelsGCST904682804.95e-03
9733Alkaline phosphatase (UKB data field 30610)GCST904680604.94e-03
9734Cervical cancerGCST900118164.93e-03
9735MLN/TNFRSF12A ratioGCST903154594.93e-03
9736Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING000007724.92e-03
9737Soft cheese likingGCST900948434.92e-03
9738GCHFR levelsGCST904693174.92e-03
9739Basal cell carcinoma (PheCode 172.21)GCST904755824.91e-03
9740Ceramide (d17:1/24:0) levelsGCST900240334.91e-03
9741AGXT/GSTA1 ratioGCST903132064.91e-03
9742Degree of unsaturationGCST905022334.91e-03
9743Volume of left central nucleusGCST904749614.88e-03
9744CX3CL1/LAYN ratioGCST903143254.88e-03
9745Glycated hemoglobin levelsGCST905664244.86e-03
97462-hydroxyisobutyrate levelsGCST902435394.85e-03
9747NCR3LG1 levelsGCST904700104.84e-03
9748DTI TBSS L2 Medial lemniscus LGCST903844854.84e-03
9749HAMP levelsGCST904516834.82e-03
9750PLA2G4A/SPINT2 ratioGCST903156714.82e-03
9751Cerebral aneurysmGCST900185954.81e-03
9752Eosinophil count varianceGCST905656894.80e-03
9753Sphingomyelin (d18:1/16:0) levelsGCST900257444.79e-03
9754CLEC4C levelsGCST904687724.79e-03
9755Docosahexaenoic acid levelsGCST905022424.75e-03
9756Poisoning by antibiotics | injuries & poisoningsUKBB000006534.75e-03
9757Trauma (confirmatory factor analysis Factor 9)GCST903093434.71e-03
9758Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900254364.71e-03
9759F9/RARRES2 ratioGCST903147494.70e-03
9760Autoimmune polyglandular failureFING000001354.69e-03
97615alpha-pregnan-3beta,20alpha-diol monosulfate (2) levelsGCST901998544.69e-03
9762F-savoury food liking (derived food-liking factor)GCST900948334.66e-03
9763HippSubfield lh volume presubiculum-headGCST900026734.66e-03
9764CD69/PLXNA4 ratioGCST903138804.63e-03
9765LGALS8/TXNDC5 ratioGCST903153214.63e-03
9766HGF/PDGFB ratioGCST903150584.62e-03
9767Milky sweets likingGCST900948024.61e-03
9768ANXA10 levelsGCST904683144.60e-03
9769Symptoms involving digestive system (PheCode 561)GCST904760694.59e-03
9770Omega-3 fatty acids to total fatty acids percentageGCST905024514.58e-03
9771CD99L2/CPM ratioGCST903139254.56e-03
9772Insulin fold change during an oral glucose tolerance test (adjusted for BMI)GCST902675674.55e-03
9773DNAJB1/EIF4B ratioGCST903145084.53e-03
9774EDAR/TREML2 ratioGCST903145924.51e-03
9775SCG2 levelsGCST904705384.50e-03
9776CLEC1B/VSIR ratioGCST903141064.50e-03
9777Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T446ECGU0004464.49e-03
9778Cancer code, self-reported: breast cancer (UKB data field 20001_1002)GCST900418864.48e-03
9779CLMP/TGFBR2 ratioGCST903141354.46e-03
9780CD164/LGMN ratioGCST903137414.45e-03
97811-arachidonoylglycerophosphocholine levelsGCST902436744.41e-03
9782GoutGCST903997014.41e-03
9783Salad dressing likingGCST900948224.38e-03
9784TNF/TNFRSF1B ratioGCST903159424.37e-03
9785T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44)GCST903206074.36e-03
9786Free cholesterol to total lipids in small HDL percentage (UKB data field 23647)GCST902697444.36e-03
9787Cancer of kidney and renal pelvis (PheCode 189.1)GCST904755954.35e-03
9788Cheesecake likingGCST900947304.35e-03
9789Loneliness (weighted GWA)GCST902672894.33e-03
9790CCL14/CST3 ratioGCST903136794.33e-03
9791Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)FING000010674.33e-03
9792COLEC12/OGN ratioGCST903141844.31e-03
9793PDZK1 levelsGCST904702034.30e-03
9794ODAM levelsGCST904701154.30e-03
9795COLEC12/TAFA5 ratioGCST903141854.28e-03
9796rfMRI amplitudes (ICA100 node 2)GCST900045904.28e-03
9797DTI TBSS MD Body of corpus callosumGCST903845754.26e-03
9798COL28A1 levelsGCST904688154.26e-03
9799Synonym | Fluid intelligence / reasoningUKBB000008024.25e-03
9800aseg lh volume PallidumGCST900026234.24e-03
9801Right-hemisphere dorsal attention network to hippocampus white-matter structural connectivityGCST903028104.24e-03
9802ICAM2/SELE ratioGCST903151204.22e-03
9803Omega-3 fatty acids to total fatty acids percentageGCST905024504.21e-03
9804Other demyelinating diseases of the central nervous systemFING000009954.20e-03
9805PODXL2 levelsGCST904702794.20e-03
9806Basal cell carcinoma (MTAG)GCST901374114.19e-03
9807AmygNuclei rh volume Cortical-nucleusGCST900026644.18e-03
9808Diarrhoea and gastroenteritis of presumed infectious originFING000004204.18e-03
9809CASP8/RILP ratioGCST903136574.17e-03
9810Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T431ECGU0004314.16e-03
9811X-08402 levelsGCST902435384.15e-03
9812Lichen sclerosus et atrophicusFING000007234.13e-03
9813Malignant neoplasm of female breast | neoplasmsUKBB000004264.13e-03
9814Saturated fatty acids to total fatty acids percentageGCST905026964.13e-03
9815ST13 levelsGCST904707514.12e-03
9816Lysine levelsGCST902004024.12e-03
9817DNAJB6 levelsGCST904690144.11e-03
9818VitiligoFING000014434.11e-03
9819TIMP3 levelsGCST904708714.10e-03
9820Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486ECGA0004864.10e-03
9821Facial pigmentation measurement (UV light)GCST900022834.09e-03
9822Other non-toxic goitre | Disorders of thyroid glandUKBB000006174.08e-03
9823RBP2 levelsGCST904704384.07e-03
9824GSTA1 levelsGCST904694114.07e-03
9825BAG6 levelsGCST904684184.07e-03
9826Valine levelsGCST905001774.06e-03
9827Depression/anxiety (standard GWA)GCST902672764.05e-03
9828All dysplastic lesions of the cervix uteriFING000000604.05e-03
9829Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST900418394.03e-03
9830LILRB4 levelsGCST904267084.03e-03
9831CTRC levelsGCST904689064.03e-03
9832NRCAM/PCDH17 ratioGCST903155534.02e-03
9833Migraine (PheCode 340)GCST904758374.02e-03
9834Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490ECGA0004904.01e-03
9835Phosphatidylcholine-O_38:5_[M+H]1+/Phosphatidylcholine-P_38:4_[M+H]1+ levelsGCST900603754.01e-03
9836Physical activity (Principal component 2)GCST900614234.00e-03
9837MESD/VASH1 ratioGCST903154253.99e-03
9838BTN2A1/CSF1 ratioGCST903135413.98e-03
9839Multiple sclerosisGCST904758333.94e-03
9840CDKN2D/TACC3 ratioGCST903139923.90e-03
9841FCAMR levelsGCST904691963.88e-03
9842SNX5 levelsGCST904707023.88e-03
9843INPPL1 levelsGCST904696193.87e-03
9844ANKMY2 levelsGCST904683093.87e-03
9845Left-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST903026823.87e-03
9846FAM174A levelsGCST902419143.87e-03
9847O-sulfo-l-tyrosine levelsGCST902436233.87e-03
9848TEK levelsGCST900120133.86e-03
9849CD86 levelsGCST904686543.85e-03
9850CANT1/VSIR ratioGCST903136213.85e-03
9851CA11 levelsGCST904685063.84e-03
9852ANGPT1 levelsGCST904683003.83e-03
9853Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions)FING000001013.79e-03
9854Facial skin colour (CIELAB index b* value)GCST900200563.78e-03
9855FLT4 levelsGCST904692523.78e-03
9856AHCY levelsGCST904682593.77e-03
9857SERPINA9 levelsGCST904705883.76e-03
9858Systemic lupus erythematosusGCST900118663.73e-03
9859CA4/PECAM1 ratioGCST903135863.71e-03
9860T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 28)GCST903208473.71e-03
9861Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436ECGU0004363.71e-03
9862Type of accommodation lived in - A flat, maisonette or apartment | HouseholdUKBB000008683.70e-03
9863Cystatin C productionGCST902679863.70e-03
9864Omega-3 fatty acids levelsGCST904991393.70e-03
9865Noninfectious gastroenteritis | digestiveUKBB000005263.69e-03
9866ENPP7 levelsGCST904691183.68e-03
98673-amino-2-piperidone levelsGCST902001883.67e-03
9868ANXA1 levelsGCST902402963.63e-03
9869Nasal polyp | Other diseases of upper respiratory tractUKBB000004933.63e-03
9870SPART levelsGCST904707193.63e-03
9871Takes medication for asthma?GCST904752603.62e-03
9872DNMBP levelsGCST904690233.61e-03
9873LILRB2 levelsGCST904697773.60e-03
9874Primary angle-closure glaucomaFING000012103.60e-03
9875BST1 levelsGCST904684743.58e-03
9876Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T482ECGA0004823.58e-03
9877N-formylmethionine levelsGCST902003433.57e-03
9878ANXA3/BID ratioGCST903132793.57e-03
9879CXCL17/LAMP3 ratioGCST903143403.54e-03
9880Depressive symptomatology (confirmatory factor analysis Factor 2)GCST903093373.53e-03
9881TP53I3 levelsGCST904709373.53e-03
9882SNAP29/SPARC ratioGCST903158603.53e-03
9883CD59/SCARB2 ratioGCST903138593.51e-03
9884IDP T1 FAST ROIs L front operc cortexGCST900025313.51e-03
9885IDP dMRI TBSS FA FornixGCST900038823.51e-03
9886VNN2 levelsGCST904710443.49e-03
9887CLIP2 levelsGCST904687823.48e-03
9888SIRT1 levelsGCST904706413.48e-03
9889Scar conditions and fibrosis of skin (PheCode 701.2)GCST904761983.48e-03
9890SSNA1 levelsGCST904707503.48e-03
9891Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)FING000007493.48e-03
9892Lysoalkylphosphatidylcholine (O-24:0) levelsGCST900248123.47e-03
9893Working memoryGCST905031163.47e-03
9894Stearoylcarnitine (C18) levelsGCST901997433.44e-03
9895Type of accommodation lived in - A house or bungalow | HouseholdUKBB000008693.44e-03
9896CDH17/PECAM1 ratioGCST903139423.42e-03
9897CCN2/MGLL ratioGCST903137143.42e-03
9898ENO2/TACC3 ratioGCST903146703.42e-03
9899Erythematosquamous dermatosis (PheCode 690)GCST904761703.41e-03
9900aparc-a2009s lh volume G-pariet-inf-SupramarGCST900029503.41e-03
9901Other follicular disordersFING000010503.40e-03
9902OLFM4 levelsGCST904701213.40e-03
9903F7/VASN ratioGCST903147453.40e-03
9904Fasting glucoseGCST902786283.40e-03
9905Degree of unsaturationGCST905027523.39e-03
9906BECN1 levelsGCST904684383.39e-03
9907SERPINE1/USP8 ratioGCST903158353.39e-03
9908Coeliac diseaseGCST904681203.38e-03
9909Other diseases of the digestive systemFING000010103.38e-03
9910ANXA4/CA13 ratioGCST903132903.38e-03
9911Right-hemisphere control network to thalamus white-matter structural connectivityGCST903028363.37e-03
9912CLMP levelsGCST904687833.37e-03
9913SLC4A1 levelsGCST904706633.35e-03
9914ANXA4/LACTB2 ratioGCST903132933.34e-03
9915F-strong flavour liking (derived food-liking factor)GCST900948513.34e-03
9916Pulmonary embolismGCST904681483.34e-03
9917NPPC levelsGCST904700753.34e-03
9918TNFRSF14/TNFSF14 ratioGCST903159363.34e-03
9919Infections of the skin and subcutaneous tissueFING000006703.33e-03
9920Operative procedures - Carpal tunnel release | Summary OperationsUKBB000005743.32e-03
9921CDH5/TEK ratioGCST903139613.32e-03
9922Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)FING000007513.31e-03
9923Carnitine levelsGCST901996213.31e-03
9924HNMT levelsGCST904694683.31e-03
9925SELL levelsGCST904705673.30e-03
9926Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levelsGCST900602773.30e-03
9927STAMBP/WWP2 ratioGCST903158883.29e-03
9928Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB000000833.29e-03
9929red blood cell count (RBC, maximum, inv-norm transformed)GCST904763453.28e-03
9930Eicosenoylcarnitine (C20:1) levelsGCST902001483.28e-03
9931Omega-6 fatty acid levelsGCST900929333.27e-03
9932IL17D levelsGCST904695603.27e-03
9933MYO9B levelsGCST904699823.26e-03
9934Biological Mother: High blood pressureGCST904754903.25e-03
9935EIF4G1/NFATC1 ratioGCST903146373.22e-03
9936Volume of left paralaminar nucleusGCST904749853.21e-03
9937Seborrheic dermatitis (PheCode 690.1)GCST904761713.20e-03
9938Cerebrospinal fluid proline levelsGCST903182513.20e-03
9939IL18RAP levelsGCST904695663.19e-03
9940Omega-3 fatty acids to total fatty acids percentageGCST905024623.18e-03
9941RPE levelsGCST904704953.18e-03
9942rfMRI amplitudes (ICA100 node 28)GCST900046163.18e-03
9943METAP2/PFKFB2 ratioGCST903154313.18e-03
9944NUCB2 levelsGCST904701013.18e-03
9945Skin color (cheek, ITA value)GCST905027803.17e-03
99461-ribosyl-imidazoleacetate levelsGCST901998153.16e-03
9947COX5B/GFER ratioGCST903142003.16e-03
9948T1 FreeSurfer aseg Left-PallidumGCST903841463.13e-03
9949ADH4/CA5A ratioGCST903131893.10e-03
9950Illnesses of siblings - None of the above (group 1) | Family historyUKBB000003533.10e-03
9951CLEC11A levelsGCST904687643.07e-03
9952Malignant neoplasm of breast | Malignant neoplasm of breastUKBB000004243.06e-03
9953neutrophil (fraction, maximum, inv-norm transformed)GCST904755353.04e-03
9954Other/unspecified dorsalgiaFING000011243.04e-03
9955FCER2 levelsGCST904691993.04e-03
9956Feeling fed-upGCST0069473.04e-03
9957Nasal polypsGCST904681433.03e-03
9958Operative procedures - Endoscopic resection of semilunar cartilage NEC | Summary OperationsUKBB000005773.02e-03
9959ANXA3/SERPINB1 ratioGCST903132893.02e-03
9960CSNK2A1 or CSNK2B levelsGCST900889633.02e-03
9961eGFR in diabetes mellitus (strict) case-control group (minimal adjustment)GCST906247813.02e-03
9962End-diastolic bi-ventricular shape (principal component 4)GCST904484833.01e-03
9963PDGFB/SPINT2 ratioGCST903156293.01e-03
9964Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST903027793.00e-03
9965DAG1/MGLL ratioGCST903143773.00e-03
9966Lamb or mutton consumption (UKB data field 1379)GCST901329982.99e-03
9967CDH1/CST3 ratioGCST903139462.98e-03
9968IDP dMRI TBSS OD Anterior limb of internal capsule RGCST900044182.98e-03
9969FIS1/PDGFB ratioGCST903148302.98e-03
9970MMP1/MMP3 ratioGCST903154612.97e-03
9971CD300LF levelsGCST904686222.97e-03
9972ITGB6 levelsGCST904696462.97e-03
9973T1 FreeSurfer a2009s lh S postcentral areaGCST903847342.96e-03
9974Left-hemisphere default mode network to putamen white-matter structural connectivityGCST903027692.95e-03
9975Psoriatic arthropathiesFING000012252.93e-03
9976Prevotellamassilia abundance in stoolGCST900325172.93e-03
9977ST3GAL1 levelsGCST904707522.90e-03
9978Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB000006132.88e-03
9979Cancer of prostate (PheCode 185)GCST900418532.88e-03
9980METAP2/USP8 ratioGCST903154342.87e-03
9981Urea | Blood biochemistryUKBB000008852.86e-03
9982Other and unspecified tonsillitisFING000009542.86e-03
9983Otitis externaFING000011282.86e-03
9984Takes medication for skin cancer?GCST904751902.85e-03
9985Single spontaneous deliveryFING000013072.85e-03
9986CMIP levelsGCST904687952.85e-03
9987TCL1A levelsGCST904708172.85e-03
9988PLA2G4A/SNAP29 ratioGCST903156692.84e-03
9989Childhood asthma (age<16) (more control exclusions)FING000002702.84e-03
9990Glaucoma (PheCode 365)GCST0083732.83e-03
9991ARHGEF12/DECR1 ratioGCST903133492.82e-03
9992LPCAT2/SERPINB8 ratioGCST903153282.82e-03
9993Lawsonibacter sp002161175 abundance in stoolGCST900324592.80e-03
9994PACS2 levelsGCST904701412.80e-03
9995T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 102)GCST903209212.79e-03
9996Normal-pressure hydrocephalusFING000008912.79e-03
9997SIAE levelsGCST904706292.78e-03
9998Breast sizeGCST0066552.78e-03
9999PPP2R5A levelsGCST904703062.78e-03
10000SNAP23/SNAP29 ratioGCST903158552.78e-03